Revatio (sildenafil): Drug Safety Communication – Recommendation Against Use in Children

by admin on August 30, 2012

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Revatio (sildenafil): Drug Safety Communication – Recommendation Against Use in Children. According to the Food & Drug Administration FDA’s MedWatch:

Recent long-term clinical pediatric trial showed children taking a high dose of Revatio had a higher risk of death than children taking a low dose.

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Revatio (sildenafil): Drug Safety Communication – Recommendation Against Use in Children.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

Share Your Recall Comments Below!

    What Do You Think? Share Your Recall Comments!

    Previous post:

    Next post: